Annual FCF:
$220.04M+$106.06M(+93.06%)Summary
- As of today, AMRX annual free cash flow is $220.04 million, with the most recent change of +$106.06 million (+93.06%) on December 31, 2024.
- During the last 3 years, AMRX annual free cash flow has risen by +$27.65 million (+14.37%).
- AMRX annual free cash flow is now -30.85% below its all-time high of $318.21 million, reached on December 31, 2020.
Performance
AMRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
$56.42M+$67.33M(+616.92%)Summary
- As of today, AMRX quarterly free cash flow is $56.42 million, with the most recent change of +$67.33 million (+616.92%) on June 30, 2025.
- Over the past year, AMRX quarterly free cash flow has increased by +$28.21 million (+100.04%).
- AMRX quarterly free cash flow is now -76.46% below its all-time high of $239.63 million, reached on December 31, 2018.
Performance
AMRX Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$261.51M+$28.21M(+12.09%)Summary
- As of today, AMRX TTM free cash flow is $261.51 million, with the most recent change of +$28.21 million (+12.09%) on June 30, 2025.
- Over the past year, AMRX TTM free cash flow has increased by +$247.85 million (+1814.41%).
- AMRX TTM free cash flow is now -36.83% below its all-time high of $413.95 million, reached on March 31, 2021.
Performance
AMRX TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
AMRX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +93.1% | +100.0% | +1814.4% |
| 3Y3 Years | +14.4% | +158.4% | +206.7% |
| 5Y5 Years | +329.9% | -67.0% | +39.7% |
AMRX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +910.2% | -55.9% | +197.7% | at high | +785.1% |
| 5Y | 5-Year | -30.9% | +329.9% | -58.6% | +158.4% | -36.8% | +785.1% |
| All-Time | All-Time | -30.9% | +329.9% | -76.5% | +144.6% | -36.8% | +373.2% |
AMRX Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $56.42M(+616.9%) | $261.51M(+12.1%) |
| Mar 2025 | - | -$10.91M(-111.5%) | $233.29M(+6.0%) |
| Dec 2024 | $220.04M(+93.1%) | $94.94M(-21.6%) | $220.04M(+226.7%) |
| Sep 2024 | - | $121.06M(+329.3%) | $67.35M(+393.1%) |
| Jun 2024 | - | $28.20M(+216.7%) | $13.66M(+135.8%) |
| Mar 2024 | - | -$24.17M(+58.1%) | -$38.17M(-133.5%) |
| Dec 2023 | $113.97M(+519.7%) | -$57.74M(-185.7%) | $113.97M(-16.8%) |
| Sep 2023 | - | $67.37M(+385.1%) | $136.96M(+22.0%) |
| Jun 2023 | - | -$23.63M(-118.5%) | $112.26M(+185.5%) |
| Mar 2023 | - | $127.97M(+468.2%) | $39.32M(+270.1%) |
| Dec 2022 | -$27.16M(-114.1%) | -$34.76M(-181.5%) | -$23.11M(-141.1%) |
| Sep 2022 | - | $42.67M(+144.2%) | $56.21M(-34.1%) |
| Jun 2022 | - | -$96.57M(-247.3%) | $85.26M(-29.9%) |
| Mar 2022 | - | $65.55M(+47.1%) | $121.59M(-36.8%) |
| Dec 2021 | $192.39M(-39.5%) | $44.56M(-37.9%) | $192.39M(-13.8%) |
| Sep 2021 | - | $71.72M(+219.1%) | $223.15M(+21.9%) |
| Jun 2021 | - | -$60.24M(-144.2%) | $183.02M(-55.8%) |
| Mar 2021 | - | $136.35M(+81.0%) | $413.95M(+30.1%) |
| Dec 2020 | $318.21M(+432.4%) | $75.33M(+138.5%) | $318.21M(+70.0%) |
| Sep 2020 | - | $31.58M(-81.5%) | $187.22M(-33.7%) |
| Jun 2020 | - | $170.69M(+320.3%) | $282.52M(+296.3%) |
| Mar 2020 | - | $40.61M(+173.0%) | $71.28M(+174.5%) |
| Dec 2019 | -$95.73M(-162.5%) | -$55.66M(-143.9%) | -$95.73M(-148.0%) |
| Sep 2019 | - | $126.88M(+412.9%) | $199.56M(+105.0%) |
| Jun 2019 | - | -$40.55M(+67.9%) | $97.35M(+406.6%) |
| Mar 2019 | - | -$126.40M(-152.7%) | $19.21M(-87.5%) |
| Dec 2018 | $153.14M(+27.7%) | $239.63M(+871.6%) | $153.14M(+475.2%) |
| Sep 2018 | - | $24.66M(+120.8%) | -$40.81M(-27.4%) |
| Jun 2018 | - | -$118.68M(-1676.1%) | -$32.03M(-137.0%) |
| Mar 2018 | - | $7.53M(-83.5%) | $86.65M(+9.5%) |
| Dec 2017 | $119.92M(+452.7%) | $45.67M(+36.6%) | $79.12M(+1188.7%) |
| Sep 2017 | - | $33.45M(+182.2%) | -$7.27M(-133.5%) |
| Dec 2016 | $21.70M(-46.9%) | - | - |
| Dec 2016 | - | -$40.71M(-165.0%) | $21.70M(-75.5%) |
| Sep 2016 | - | $62.64M(+198.9%) | $88.47M(+1.4%) |
| Jun 2016 | - | -$63.30M(-200.4%) | $87.27M(+3.3%) |
| Mar 2016 | - | $63.08M(+142.0%) | $84.52M(+106.8%) |
| Dec 2015 | $40.88M(+504.9%) | $26.06M(-57.6%) | $40.88M(+386.9%) |
| Sep 2015 | - | $61.43M(+193.0%) | -$14.25M(+70.2%) |
| Jun 2015 | - | -$66.05M(-439.9%) | -$47.86M(-225.3%) |
| Mar 2015 | - | $19.43M(+166.9%) | $38.20M(+478.3%) |
| Dec 2014 | -$10.10M(-109.6%) | -$29.07M(-204.5%) | -$10.10M(-45.9%) |
| Sep 2014 | - | $27.82M(+39.1%) | -$6.92M(+86.7%) |
| Jun 2014 | - | $20.01M(+169.3%) | -$52.06M(-286.5%) |
| Mar 2014 | - | -$28.86M(-11.5%) | $27.91M(-73.5%) |
| Dec 2013 | $105.16M | -$25.89M(-49.5%) | $105.16M(+19.6%) |
| Sep 2013 | - | -$17.32M(-117.3%) | $87.92M(+5.2%) |
| Jun 2013 | - | $99.97M(+106.6%) | $83.55M(+1195.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | $48.39M(+212.2%) | -$7.63M(+88.3%) |
| Dec 2012 | -$65.45M(-170.8%) | -$43.12M(-98.8%) | -$65.45M(-69.9%) |
| Sep 2012 | - | -$21.69M(-346.7%) | -$38.52M(-869.7%) |
| Jun 2012 | - | $8.79M(+193.2%) | $5.00M(+119.3%) |
| Mar 2012 | - | -$9.44M(+41.7%) | -$25.89M(-7.1%) |
| Dec 2011 | -$24.17M(-110.3%) | -$16.19M(-174.1%) | -$24.17M(-1.4%) |
| Sep 2011 | - | $21.83M(+198.8%) | -$23.83M(-42.3%) |
| Jun 2011 | - | -$22.10M(-186.6%) | -$16.74M(-108.8%) |
| Mar 2011 | - | -$7.71M(+51.3%) | $191.29M(-18.1%) |
| Dec 2010 | $233.49M(+1134.3%) | -$15.85M(-154.8%) | $233.49M(-2.0%) |
| Sep 2010 | - | $28.92M(-84.4%) | $238.29M(+15.7%) |
| Jun 2010 | - | $185.93M(+439.0%) | $206.03M(+494.8%) |
| Mar 2010 | - | $34.50M(+412.1%) | $34.64M(+258.7%) |
| Dec 2009 | -$22.57M(-158.3%) | -$11.05M(-230.3%) | -$21.82M(-179.7%) |
| Sep 2009 | - | -$3.35M(-123.0%) | $27.39M(+64.7%) |
| Jun 2009 | - | $14.54M(+166.2%) | $16.63M(+695.3%) |
| Mar 2009 | - | -$21.96M(-157.6%) | $2.09M(-91.3%) |
| Dec 2008 | $38.70M(-61.4%) | $38.16M(+370.5%) | $24.05M(+270.5%) |
| Sep 2008 | - | -$14.11M(-59.8%) | -$14.11M(+62.4%) |
| Dec 2007 | $100.18M(+467.8%) | - | - |
| Dec 2006 | -$27.23M(-526.3%) | - | - |
| Dec 2005 | $6.39M(+127.0%) | - | - |
| Sep 2004 | - | -$8.83M(+57.8%) | -$37.53M(-16.2%) |
| Jun 2004 | - | -$20.92M(-807.5%) | -$32.30M(-69.1%) |
| Mar 2004 | - | $2.96M(+127.5%) | -$19.10M(+19.2%) |
| Dec 2003 | -$23.63M(+21.9%) | -$10.74M(-198.6%) | -$23.63M(-6.7%) |
| Sep 2003 | - | -$3.60M(+53.4%) | -$22.15M(+9.7%) |
| Jun 2003 | - | -$7.72M(-392.1%) | -$24.52M(-6.2%) |
| Mar 2003 | - | -$1.57M(+83.1%) | -$23.10M(+23.7%) |
| Dec 2002 | -$30.25M(+12.2%) | -$9.26M(-55.0%) | -$30.25M(+12.0%) |
| Sep 2002 | - | -$5.97M(+5.1%) | -$34.36M(+3.8%) |
| Jun 2002 | - | -$6.29M(+27.9%) | -$35.74M(+7.4%) |
| Mar 2002 | - | -$8.72M(+34.7%) | -$38.57M(-12.0%) |
| Dec 2001 | -$34.45M(-76.1%) | -$13.37M(-82.0%) | -$34.45M(-35.3%) |
| Sep 2001 | - | -$7.35M(+19.5%) | -$25.47M(-11.0%) |
| Jun 2001 | - | -$9.13M(-98.4%) | -$22.95M(-7.6%) |
| Mar 2001 | - | -$4.60M(-4.9%) | -$21.34M(-9.0%) |
| Dec 2000 | -$19.57M(-172.0%) | -$4.39M(+9.0%) | -$19.57M(-4.8%) |
| Sep 2000 | - | -$4.82M(+35.9%) | -$18.67M(-24.6%) |
| Jun 2000 | - | -$7.52M(-165.3%) | -$14.98M(-78.1%) |
| Mar 2000 | - | -$2.83M(+18.9%) | -$8.41M(-16.9%) |
| Dec 1999 | -$7.19M(-44.7%) | -$3.49M(-208.9%) | -$7.19M(-79.8%) |
| Sep 1999 | - | -$1.13M(-18.7%) | -$4.00M(-2.2%) |
| Jun 1999 | - | -$953.00K(+41.0%) | -$3.91M(+18.5%) |
| Mar 1999 | - | -$1.62M(-438.7%) | -$4.80M(+3.4%) |
| Dec 1998 | -$4.97M | -$300.00K(+71.3%) | -$4.97M(-6.4%) |
| Sep 1998 | - | -$1.04M(+43.3%) | -$4.67M(-28.8%) |
| Jun 1998 | - | -$1.84M(-3.1%) | -$3.63M(-103.1%) |
| Mar 1998 | - | -$1.79M | -$1.79M |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual free cash flow year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
- What is Amneal Pharmaceuticals, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual free cash flow?
The current annual free cash flow of AMRX is $220.04M
What is the all-time high annual free cash flow for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual free cash flow is $318.21M
What is Amneal Pharmaceuticals, Inc. annual free cash flow year-on-year change?
Over the past year, AMRX annual free cash flow has changed by +$106.06M (+93.06%)
What is Amneal Pharmaceuticals, Inc. quarterly free cash flow?
The current quarterly free cash flow of AMRX is $56.42M
What is the all-time high quarterly free cash flow for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly free cash flow is $239.63M
What is Amneal Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
Over the past year, AMRX quarterly free cash flow has changed by +$28.21M (+100.04%)
What is Amneal Pharmaceuticals, Inc. TTM free cash flow?
The current TTM free cash flow of AMRX is $261.51M
What is the all-time high TTM free cash flow for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high TTM free cash flow is $413.95M
What is Amneal Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
Over the past year, AMRX TTM free cash flow has changed by +$247.85M (+1814.41%)